News
MDGL ▲ +0.2% - Madrigal Pharmaceuticals, Inc.
MDGL ▲ +0.2% - Madrigal Pharmaceuticals, Inc.
$MDGL - Madrigal Announces Publication in the Journal of Hepatology Demonstrating Consistent Rezdiffra Efficacy Across Common MASH Genetic Risk Variants
06-OCT-2026 08:03 AM ET
Share this post
More filings for $MDGL
MDGL ▼ -0.0% - Madrigal Pharmaceuticals, Inc.Oct 20, 2026MDGL ▲ +1.0% - Madrigal Pharmaceuticals, Inc.Sep 16, 2026$MDGL SEC Filing Update (29-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 29, 2026
View full $MDGL filing history →💬 Comments
Loading comments…
Leave a comment